Description
LB I Group was a New York, New York based private equity firm which was a direct wholly-owned subsidiary of Lehman Brothers.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
0000 0000000000000 | 24-Mar-2008 | 0000 | 00000 | Pharmaceuticals | Generating Revenue/Not Profitable | |
00000000 00000000 | 16-Feb-2007 | 0000 | 000.00 | Biotechnology | Generating Revenue/Not Profitable | |
0000000 | 07-Nov-2006 | 0000 | 0000 | Pharmaceuticals | Generating Revenue | |
00000000 00000000 | 08-May-2006 | 0000 | 0000 | Biotechnology | Generating Revenue/Not Profitable | |
CASI Pharmaceuticals | 27-Dec-2004 | PIPE | 0000 | Biotechnology | Generating Revenue/Not Profitable |
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
00000000 00000000 | 05-Feb-2020 | 000000000 00000000 | 000.00 |
00000 000000000000 | 28-Feb-2018 | 000000000000000000 | 00.00 |
0000 0000000000000 | 23-Jan-2012 | 000000000 00000000 | 0000 |
0000 0000000000000 | 21-Jun-2010 | 000000000000000000 | 00.00 |
Cytogen | 08-May-2008 | Buyout/LBO | 0000 |